✦ LIBER ✦

Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases

✍ Scribed by Liang-Ping Xia; Hui-Juan Qiu; Xu-Xian Chen; Pi-Li Hu; Gui-Fang Guo; Fang Wang; Fei-Fei Zhou; Wen-Zhuo He; Bei Zhang; Li Zhang

Book ID: 107577323
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 406 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9709-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term outcomes of cetuximab combine

Short-term outcomes of cetuximab combined with standard chemotherapy as non-first line setting for patients with non-small cell lung cancer: a report of 6 cases

✍ Fang Wang; Liangping Xia; Guifang Guo; Huijuan Qiu; Feifei Zhou; Bei Zhang; Li Z 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 274 KB

A phase II clinical trial of celecoxib c

A phase II clinical trial of celecoxib combined with platinum-based regimen as first-line chemotherapy for advanced non-small cell lung cancer patients with cyclooxygenase-2 positive expression

✍ Jun Zhao; Zhi-jie Wang; Jian-chun Duan; Qing-zhi Guo; Hua Bai; Lu Yang; Tong-ton 📂 Article 📅 2009 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 521 KB

Combination of topotecan and etoposide a

Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy

✍ Hye Jin Choi; Byoung Chul Cho; Sang Joon Shin; Seong Ha Cheon; Jong Yul Jung; Jo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 245 KB